The Short Version
A retail channel survey released this summer reveals a clear bifurcation in hemp product category performance: products built on compliant, documented hemp ingredients are gaining shelf space, while those associated with unclear compliance status or synthetic-derived cannabinoids are being actively reduced or delisted. For B2B ingredient suppliers and the formulators wh buy from them, this is the most concrete market signal yet that retail channels are front-running the November 12 deadline.
What the Survey Covers
The survey tracked shelf space allocation and buyer decision-making across natural products retailers, pharmacy chains, specialty wellness stores, and online marketplace platforms. Collectively, the participating retailers represent several billion dollars in annual hemp-related product sales. The results reflect decisions made through June 2026 and projected decisions through the November 12 deadline.
The Winners: Categories Gaining Shelf Space
Full-Spectrum CBD Oil Tinctures (Compliant)
Full-spectrum CBD oil products from brands with clear compliance documentation — third-party HPLC testing, verifiable total THC calculations, and GMP-certified manufacturing — are gaining shelf space in nearly every retail channel surveyed. Retailers cite consumer trust and regulatory confidence as the primary drivers. The key qualifier is "compliant": full-spectrum products that cannot demonstrate HPLC-based testing or that carry ambiguous THC claims are not in this category.
CBG and CBC Isolate Products
CBG (cannabigerol) and CBC (cannabichromene) isolate products are growing disproportionately, driven by retailer interest in diversifying the hemp category away from THC-adjacent positioning. These cannabinoids have clear regulatory status under the federal framework, are not subject to the 0.4mg total THC per container limit in the same way as THC-adjacent full-spectrum products, and are attracting formulation interest from sports nutrition and functional food brands.
Hemp-Derived Topicals with Explicit Compliance Claims
Topicals are performing well because the THC absorption risk is lower and the compliance documentation is simpler. Retailers are actively expanding topical hemp sections, particularly for products that carry visible third-party testing documentation and avoid therapeutic health claims.
Water-Soluble Hemp Extracts in Beverage Applications
The water-soluble hemp extract category — serving the hemp beverage and functional drink segment — is growing, fueled by major beverage brand investments and retailer interest in the functional beverage category. Compliant water-soluble hemp extracts are gaining listing opportunities in grocery and c-store channels that weren't available 18 months ago.
The Losers: Categories Losing Shelf Space
Delta-8 and Synthetic Cannabinoid Products
Retailers are clearing delta-8 THC, HHC, THC-O, and other synthetic or semi-synthetic cannabinoid products at an accelerating rate. Some chains have already completed the process; others are targeting September or October as their delisting date to avoid being caught holding non-compliant inventory on November 12. Brands built primarily on delta-8 products are facing an existential shelf space crisis, and the ingredient suppliers to those brands are experiencing meaningful volume declines.
High-Potency Hemp Products Without Clear Compliance Documentation
Products marketed on potency claims — "extra strength," "maximum potency," "high CBD" — without corresponding third-party testing documentation are being scrutinized by buyers. Multiple retail chains have added a documentation requirement to their hemp product onboarding process that was not present 12 months ago.
Products from Brands That Haven't Communicated Compliance Readiness
Perhaps the most significant finding is this: retailers are not waiting for November 12 to make their compliance judgments. Brands that have not proactively communicated compliance status to their retail partners are being treated as suspect. Several retailers surveyed reported declining to re-order from brands that didn't respond to compliance questionnaires sent in Q1 2026.
What Retailers Are Specifically Asking Brands
The survey asked participating retailers what documentation they're now requiring from hemp brands. The most common requirements:
- Certificate of Analysis from a DEA-registered, ISO 17025-accredited laboratory (100% of surveyed retailers)
- Proof of GMP-compliant manufacturing (76%)
- Written statement that no synthetic cannabinoids (delta-8, HHC, THC-O) are present in the product or its ingredients (81%)
- Total THC calculation using the federal formula: delta-9 THC + (THCA × 0.877) (67%)
- Supplier documentation showing hemp origin and chain of custody (52%)
For B2B ingredient suppliers, these retailer requirements translate directly into what your customers — the brands and formulators buying your ingredient — will soon be asking you for. The requirement chain runs upstream.
Implications for Ingredient Suppliers and Formulators
The retail channel is not waiting for regulatory enforcement. It is pre-emptively restructuring its hemp category based on compliance confidence — and it is doing so with enough lead time that brands have an opportunity to respond.
For formulators building products intended for retail placement, the message is direct: the ingredient you use is now part of your retail compliance story. Retailers asking for chain of custody documentation are, in effect, asking about your supplier. A supplier whose documentation doesn't support your retail compliance filing is a supplier that could cost you a listing.
For ingredient suppliers, this retail dynamic creates a commercial reality that reinforces the regulatory one: compliance is not just a legal obligation — it's a prerequisite for your customers' market access.
Action Steps for B2B Ingredient Buyers
- Review your retail customers' compliance questionnaires and identify which documentation items trace back to your ingredient supplier
- Confirm your supplier can support every documentation requirement in those questionnaires
- If you're developing new products for retail introduction in Q3 or Q4 2026, verify retailer compliance requirements before finalizing your ingredient specification
Low Gravity Hemp supplies documented, compliant hemp ingredients for formulators serving the full range of retail channels. Full documentation packages available on request.
